Cargando…

Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which caused coronavirus diseases (COVID-19) in late 2019 in China created a devastating economical loss and loss of human lives. To date, 11 variants have been identified with minimum to maximum severity of infection and surges in cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahalakshmi, V., Balobaid, Awatef, Kanisha, B., Sasirekha, R., Ramkumar Raja, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048108/
https://www.ncbi.nlm.nih.gov/pubmed/36981511
http://dx.doi.org/10.3390/healthcare11060854
_version_ 1785014097656414208
author Mahalakshmi, V.
Balobaid, Awatef
Kanisha, B.
Sasirekha, R.
Ramkumar Raja, M.
author_facet Mahalakshmi, V.
Balobaid, Awatef
Kanisha, B.
Sasirekha, R.
Ramkumar Raja, M.
author_sort Mahalakshmi, V.
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which caused coronavirus diseases (COVID-19) in late 2019 in China created a devastating economical loss and loss of human lives. To date, 11 variants have been identified with minimum to maximum severity of infection and surges in cases. Bacterial co-infection/secondary infection is identified during viral respiratory infection, which is a vital reason for morbidity and mortality. The occurrence of secondary infections is an additional burden to the healthcare system; therefore, the quick diagnosis of both COVID-19 and secondary infections will reduce work pressure on healthcare workers. Therefore, well-established support from Artificial Intelligence (AI) could reduce the stress in healthcare and even help in creating novel products to defend against the coronavirus. AI is one of the rapidly growing fields with numerous applications for the healthcare sector. The present review aims to access the recent literature on the role of AI and how its subfamily machine learning (ML) and deep learning (DL) are used to curb the pandemic’s effects. We discuss the role of AI in COVID-19 infections, the detection of secondary infections, technology-assisted protection from COVID-19, global laws and regulations on AI, and the impact of the pandemic on public life.
format Online
Article
Text
id pubmed-10048108
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100481082023-03-29 Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic Mahalakshmi, V. Balobaid, Awatef Kanisha, B. Sasirekha, R. Ramkumar Raja, M. Healthcare (Basel) Review The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which caused coronavirus diseases (COVID-19) in late 2019 in China created a devastating economical loss and loss of human lives. To date, 11 variants have been identified with minimum to maximum severity of infection and surges in cases. Bacterial co-infection/secondary infection is identified during viral respiratory infection, which is a vital reason for morbidity and mortality. The occurrence of secondary infections is an additional burden to the healthcare system; therefore, the quick diagnosis of both COVID-19 and secondary infections will reduce work pressure on healthcare workers. Therefore, well-established support from Artificial Intelligence (AI) could reduce the stress in healthcare and even help in creating novel products to defend against the coronavirus. AI is one of the rapidly growing fields with numerous applications for the healthcare sector. The present review aims to access the recent literature on the role of AI and how its subfamily machine learning (ML) and deep learning (DL) are used to curb the pandemic’s effects. We discuss the role of AI in COVID-19 infections, the detection of secondary infections, technology-assisted protection from COVID-19, global laws and regulations on AI, and the impact of the pandemic on public life. MDPI 2023-03-14 /pmc/articles/PMC10048108/ /pubmed/36981511 http://dx.doi.org/10.3390/healthcare11060854 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mahalakshmi, V.
Balobaid, Awatef
Kanisha, B.
Sasirekha, R.
Ramkumar Raja, M.
Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic
title Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic
title_full Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic
title_fullStr Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic
title_full_unstemmed Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic
title_short Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic
title_sort artificial intelligence: a next-level approach in confronting the covid-19 pandemic
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048108/
https://www.ncbi.nlm.nih.gov/pubmed/36981511
http://dx.doi.org/10.3390/healthcare11060854
work_keys_str_mv AT mahalakshmiv artificialintelligenceanextlevelapproachinconfrontingthecovid19pandemic
AT balobaidawatef artificialintelligenceanextlevelapproachinconfrontingthecovid19pandemic
AT kanishab artificialintelligenceanextlevelapproachinconfrontingthecovid19pandemic
AT sasirekhar artificialintelligenceanextlevelapproachinconfrontingthecovid19pandemic
AT ramkumarrajam artificialintelligenceanextlevelapproachinconfrontingthecovid19pandemic